• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Marken Acquires Three European Logistics Companies

Share:

July 22, 2019

RESEARCH TRIANGLE PARK, N.C., July 15, 2019 /PRNewswire/ — Marken announced today that they have acquired HRTL based in Italy along with two additional companies in Austria and Hungary under the respective names of HETO and Der Kurier. Together the group operates with offices in Vienna, Milan, Rome, and Gyor (near Budapest) to deliver 7,000 clinical trial shipments per month. This brings Marken’s total network of sites to 51, including 10 GMP qualified clinical storage depots. The acquisition further strengthens Marken’s commitment to providing logistics services to the pharmaceutical and life sciences industries in Europe.

HRTL was founded in 2011 as a specialist courier serving the clinical trials industry. The group has since acquired its own licenses to operate in their respective countries and developed strong relationships with local providers, airlines and customs brokers. Each of the group’s locations are situated in close proximity to major airports to provide maximum flexibility for expediting time and temperature-sensitive shipments.

The acquisition by Marken will expand its core clinical trials logistics opportunities in central and eastern Europe. Italy, Hungary and Austria are important sources of drug manufacturing, particularly drugs which are manufactured in sterile format. Sterile drug products are particularly sensitive and require specific temperature conditions during transport to ensure stability. Eastern and Central Europe are also important locations for recruitment of clinical trial patients and this acquisition further strengthens Marken’s biologic sample services in the region. Marken’s hybrid services, which employ the use of UPS’ network and airline, will be offered to and from gateway airports in Rome, Milan, Vienna and Budapest.

Wes Wheeler, Marken’s Chief Executive Officer, commented, “The acquisition of this group of companies is an extension of Marken’s growth and it satisfies our need for a physical presence in Italy, Austria and Hungary. Marken will quickly integrate these three new companies into the Marken network and provide a more robust operating presence in Europe. Our goal is always to provide best in class supply chain services and this acquisition makes us stronger. We welcome the three companies and their employees to our family.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Date: 22/07/2019

Source : Marketwatch

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Astrotech Begins Search for Strategic AcquisitionsAstrotech Begins Search for Strategic Acquisitions
  • Precision Optics Acquires Lighthouse Imaging, a Leading Optical Imaging Electronics and Systems CompanyPrecision Optics Acquires Lighthouse Imaging, a Leading Optical Imaging Electronics and Systems Company
  • Pharos Capital’s Complete Health Acquires Birmingham Internal Medicine AssociatesPharos Capital’s Complete Health Acquires Birmingham Internal Medicine Associates
  • PTC Therapeutics to Acquire Censa for $10 Million in Cash, $41 Million in Stock and MorePTC Therapeutics to Acquire Censa for $10 Million in Cash, $41 Million in Stock and More
  • Heat Biologics Announces Collaboration with Waisman Biomanufacturing to Manufacture COVID-19 VaccineHeat Biologics Announces Collaboration with Waisman Biomanufacturing to Manufacture COVID-19 Vaccine
  • Tech Air Announces Acquisition of Tri-Star GasesTech Air Announces Acquisition of Tri-Star Gases
  • 4 Hospitals Leveraging Social Media to Improve Patient Engagement4 Hospitals Leveraging Social Media to Improve Patient Engagement
  • AEON Biopharma and Priveterra Acquisition Corp. Announce Filing of S-4 Registration Statement for Proposed Business CombinationAEON Biopharma and Priveterra Acquisition Corp. Announce Filing of S-4 Registration Statement for Proposed Business Combination

Trending This Week

  • Denials Management Named Most Time-Consuming Task in RCM
  • Why Adopting Value-Based Care Models for Autism Care Is Imperative
  • Why AI-Driven Cancer Screening Will Soon Become Standard of Care
  • Bioventus Completes Divestiture of its Wound Business
  • Enzo Biochem Reports Significant Progress Toward Completing the Clinical Lab Asset Sale
  • eMolecules Acquires Specs Compound Handling B.V.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications